✦ LIBER ✦

Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia

✍ Scribed by M Villa; E Lage; S Ballesteros; E Cañas; M Sánchez; A Ordóñez; J.M Borrego; R Hinojosa; J.M Cisneros

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of the cytomegalovirus pp65 antigene

✍ B.H. Tan; N.L. Chlebicka; J.G. Hong Low; T.Y.R. Chong; K.P. Chan; Y.T. Goh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Preemptive Therapy in the Prevention of

✍ Casquero, S.; Rangel, D.; Lage, E.; Sobrino, M.; Cristobo, P.; Cordero, E.; Cisn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Preemptive Therapy With Intravenous Ganc

✍ V. Monforte; A. Román; J. Gavaldà; C. Bravo; P. Gispert; A. Pahissa; F. Morell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Preemptive Therapy for the Prevention of

✍ N. Paudice; A. Mehmetaj; M. Zanazzi; L. Moscarelli; R. Piperno; L. Di Maria; E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Role of CMV antigenemia directed preempt

✍ S Husain; K.R McCurry; J.H Dauber; R Zomak; P Williams; S Kusne 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Usefulness of pp65 antigenemia and virem

✍ Jordi Reina; Francisca Ballesteros; Juan Gasco; Maria Munar; Margarita Mari 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 53 KB